Fredrik Ullman
Chief Executive Officer at Indical Bioscience GmbH
Net worth: 11 M $ as of 2024-03-30
Profile
Fredrik Ullman holds the position of Chief Executive Officer of Vimian Group AB.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
VIMIAN GROUP AB
0.47% | 2022-12-30 | 2,388,414 ( 0.47% ) | 7 M $ | 2024-03-30 |
VIMIAN GROUP AB
8.25% | 2022-12-30 | 1,214,554 ( 8.25% ) | 4 M $ | 2024-03-30 |
Fredrik Ullman active positions
Companies | Position | Start |
---|---|---|
Innoverse GmbH | Corporate Officer/Principal | - |
Indical Bioscience GmbH
Indical Bioscience GmbH Miscellaneous Commercial ServicesCommercial Services INDICAL BIOSCIENCE GmbH provides solutions for molecular diagnostics for vet-specific applications. It offers diagnostics for better animal and human health. The company was founded in 1996 and is headquartered in Leipzig, Germany. | Chief Executive Officer | - |
Former positions of Fredrik Ullman
Companies | Position | End |
---|---|---|
VIMIAN GROUP AB | Chief Executive Officer | 2023-12-31 |
Training of Fredrik Ullman
Royal Institute of Technology | Graduate Degree |
Swiss Federal Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
VIMIAN GROUP AB | Health Technology |
Private companies | 2 |
---|---|
Indical Bioscience GmbH
Indical Bioscience GmbH Miscellaneous Commercial ServicesCommercial Services INDICAL BIOSCIENCE GmbH provides solutions for molecular diagnostics for vet-specific applications. It offers diagnostics for better animal and human health. The company was founded in 1996 and is headquartered in Leipzig, Germany. | Commercial Services |
Innoverse GmbH |
- Stock Market
- Insiders
- Fredrik Ullman